The RA Domain of Ste50 Adaptor Protein Is Required for Delivery of Ste11 to the Plasma Membrane in the Filamentous Growth Signaling Pathway of the Yeast Saccharomyces cerevisiae

Abstract

In Saccharomyces cerevisiae, pheromone response requires Ste5 scaffold protein, which ensures efficient G-protein-dependent recruitment of mitogen-activated protein kinase (MAPK) cascade components Ste11 (MAPK kinase kinase), Ste7 (MAPK kinase), and Fus3 (MAPK) to the plasma membrane for activation by Ste20 protein kinase. Ste20, which phosphorylates Ste11 to initiate signaling, is activated by binding to Cdc42 GTPase (membrane anchored via its C-terminal geranylgeranylation). Less clear is how activated and membrane-localized Ste20 contacts Ste11 to trigger invasive growth signaling, which also requires Ste7 and the MAPK Kss1, but not Ste5. Ste50 protein associates constitutively via an N-terminal sterile-alpha motif domain with Ste11, and this interaction is required for optimal invasive growth and hyperosmotic stress (high-osmolarity glycerol [HOG]) signaling but has a lesser role in pheromone response. We show that a conserved C-terminal, so-called “Ras association” (RA) domain in Ste50 is also essential for invasive growth and HOG signaling in vivo. In vitro the Ste50 RA domain is not able to associate with Ras2, but it does associate with Cdc42 and binds to a different face than does Ste20. RA domain function can be replaced by the nine C-terminal, plasma membrane-targeting residues (KKSKKCAIL) of Cdc42, and membrane-targeted Ste50 also suppresses the signaling deficiency of cdc42 alleles specifically defective in invasive growth. Thus, Ste50 serves as an adaptor to tether Ste11 to the plasma membrane and can do so via association with Cdc42, thereby permitting the encounter of Ste11 with activated Ste20.

Supplemental material for this article may be found at http://mcb.asm.org/.

We thank L. Bardwell, B. Cairns, R. W. Davis, D. Drubin, B. Errede, T. Handel, C. Inouye, D. I. Johnson, K. Kozminski, G. S. Martin, H.-U. Mösch, S. O'Rourke, M. Peter, F. Posas, J. Rine, H. Saito, J. Shimoni, D. Voora, and M. Whiteway for generous gifts of reagents and/or useful advice.

This work was supported by postdoctoral fellowship 99-20069Y from the American Heart Association, NIH-NRSA postdoctoral fellowship GM20022, and NCI postdoctoral traineeship CA09041 (to D.M.T.); by a University of California President's Undergraduate Research Fellowship (to J.E.B.); and by NIH research grant GM21841 and resources provided by the Berkeley campus Cancer Research Laboratory (to J.T.).